Skip to main content
Clinical Trials/ACTRN12616000534482
ACTRN12616000534482
Active, not recruiting
未知

Evaluation of the Role Of Magnetic Resonance Imaging (MRI) in Mucosal Primary Head and Neck Cancer

Dr Myo Min0 sites34 target enrollmentApril 26, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Head and Neck Cancer
Sponsor
Dr Myo Min
Enrollment
34
Status
Active, not recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 26, 2016
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr Myo Min

Eligibility Criteria

Inclusion Criteria

  • 18 years or older
  • \- Have the ability to give informed consent
  • \- Histologically\-proven invasive primary squamous cell carcinoma of mucosal primary head and neck region or patients with tumours strongly suspicious for mucosal primary head and neck cancer due to clinical features AND fine needle aspiration (FNA) cytology assessment
  • \- Primary mucosal head and neck cancer (greater than or equal to T2 and/or greater than or equal to N1\) AND no evidence of metastatic disease on staging PET/CT or CT (chest \+/\- abdomen \+/\- pelvis)
  • \- Patient undergoing curative intent primary radiotherapy \+/\- chemotherapy

Exclusion Criteria

  • \- Contraindication to MRI studies including significant claustrophobia, pacemaker/implantable defibrillator, implanted metals eg. Intraocular clips, and/or known allergic reaction to Gadolinium (Gd)\-DTPA
  • \- Previous radiotherapy and/or surgery in the head and neck region
  • \- Other malignancy (history of malignancy within 5 years)
  • \- Pregnant

Outcomes

Primary Outcomes

Not specified

Similar Trials